Kitty Yale

Our Team


Kitty Yale
EVP & Chief Development Officer

Kitty Yale is Executive Vice President and CDO of Akero Therapeutics. Yale joins Akero from Gilead Sciences, Inc. where she led global clinical operations and management of the company’s oncology, HIV, inflammation and liver disease trials.

Prior to joining Akero, Kitty held senior clinical research and operations roles at Gilead Sciences and Roche Global Development. Most recently, as VP of Clinical Operations at Gilead, she led global development programs resulting in eight drug approvals in the US, EMEA, Canada, Korea, Japan and China.